A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...

It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

In a milestone for cellular research, eMBR Genomics and Axio BioPharma announce the first commercial availability of MKLP1 ...

Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.

Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...

Fighting off infections when one has a chronic disease is a common problem, and during the COVID-19 pandemic that scenario ...

The holy grail of pandemic preparedness is being able to predict how a virus will evolve just by looking at its genetic ...

NIH researchers identified MAD21-101, a novel antibody targeting a previously unexplored epitope on the malaria parasite.

Study reveals surprising connection between common childhood virus CMV and Alzheimer's disease, offering new insights into ...